Acurx Pharmaceuticals Inc (NASDAQ:ACXP)
| 3.58 Delayed Data As of Mar 27 |  +0.04 / +1.13%Today’s Change | 2.33 Today|||52-Week Range 4.85 | -10.05% Year-to-Date |
Latest ACXP News | Press Releases
No recent news for Acurx Pharmaceuticals Inc.
Today’s Trading
| Previous close | 3.54 |
| Today’s open | 3.43 |
| Day’s range | 3.42 - 3.68 |
| Volume | 6,337 |
| Average volume (3 months) | 31,053 |
| Market cap | -- |
Data as of 3:59pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | +10.40% |
| Earnings growth (this year) | +23.51% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | May 10, 2023 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$12.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
